As of 2025-11-13, the Relative Valuation of Moberg Pharma AB (publ) (MOB.ST) is (78.03) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 10.28 SEK, the upside of Moberg Pharma AB (publ) based on Relative Valuation is -859.0%.
The range of the Relative Valuation is (69.83) - (83.33) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 11.5x | 9.8x |
| Forward P/E multiples | 9.6x - 13.1x | 11.7x |
| Fair Price | (69.83) - (83.33) | (78.03) |
| Upside | -779.2% - -910.6% | -859.0% |
| Date | P/E |
| 2025-11-11 | -1.42 |
| 2025-11-10 | -1.39 |
| 2025-11-07 | -1.46 |
| 2025-11-06 | -1.46 |
| 2025-11-05 | -1.36 |
| 2025-11-04 | -1.07 |
| 2025-11-03 | -1.09 |
| 2025-10-31 | -1.09 |
| 2025-10-30 | -1.08 |
| 2025-10-29 | -1.09 |
| 2025-10-28 | -1.10 |
| 2025-10-27 | -1.11 |
| 2025-10-24 | -1.13 |
| 2025-10-23 | -1.11 |
| 2025-10-22 | -1.08 |
| 2025-10-21 | -1.15 |
| 2025-10-20 | -1.12 |
| 2025-10-17 | -1.12 |
| 2025-10-16 | -1.14 |
| 2025-10-15 | -1.12 |
| 2025-10-14 | -1.12 |
| 2025-10-13 | -1.13 |
| 2025-10-10 | -1.12 |
| 2025-10-09 | -1.13 |
| 2025-10-08 | -1.19 |
| 2025-10-07 | -1.14 |
| 2025-10-06 | -1.17 |
| 2025-10-03 | -1.16 |
| 2025-10-02 | -1.21 |
| 2025-10-01 | -1.21 |
| 2025-09-30 | -1.22 |
| 2025-09-29 | -1.24 |
| 2025-09-26 | -1.17 |
| 2025-09-25 | -1.17 |
| 2025-09-24 | -1.18 |
| 2025-09-23 | -1.20 |
| 2025-09-22 | -1.21 |
| 2025-09-19 | -1.24 |
| 2025-09-18 | -1.24 |
| 2025-09-17 | -1.22 |
| 2025-09-16 | -1.21 |
| 2025-09-15 | -1.20 |
| 2025-09-12 | -1.23 |
| 2025-09-11 | -1.24 |
| 2025-09-10 | -1.25 |
| 2025-09-09 | -1.23 |
| 2025-09-08 | -1.21 |
| 2025-09-05 | -1.24 |
| 2025-09-04 | -1.31 |
| 2025-09-03 | -1.36 |